Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening

被引：24

作者：

Boers, Aniek ^{[1
]}

Wang, Rong ^{[1
]}

Slagter-Menkema, Lorian ^{[2
]}

van Hemel, Bettien M. ^{[2
]}

Ghyssaert, Hilde ^{[3
]}

van der Zee, Ate G. J. ^{[1
]}

Wisman, G. Bea A. ^{[1
]}

Schuuring, Ed ^{[2
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Div Gynecol Oncol, Dept Obstet & Gynecol, Groningen, Netherlands

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands

[3] AZ St Jan Brugge Oostende, Dept Pathol, Brugge, Belgium

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2014年 / 52卷 / 12期

关键词：

HIGH-RISK HPV; HYBRID CAPTURE 2; WOMEN; PERFORMANCE; CYTOLOGY; ASSAY; EXPERIENCE;

D O I：

10.1128/JCM.02716-14

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This study demonstrates that both the clinical sensitivity and specificity of the Cervista HPV HR test for high-risk human papillomavirus (HPV) detection are not inferior to those of the Hybrid Capture 2 (HC2) test. The intra- and interlaboratory reproducibilities of Cervista were 92.0% (kappa, 0.83) and 90.4% (kappa, 0.80), respectively. The Cervista HPV HR test fulfills all the international HPV test requirements for cervical primary screening purposes.

引用

页码：4391 / 4393

页数：3

共 17 条

[11]

Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI [10.1097/LGT.0b013e318287d329, 10.1097/AOG.0b013e3182883a34]

[12] Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older [J].

Meijer, Chris J. L. M. ;

Berkhof, Johannes ;

Castle, Philip E. ;

Hesselink, Albertus T. ;

Franco, Eduardo L. ;

Ronco, Guglielmo ;

Arbyn, Marc ;

Bosch, F. Xavier ;

Cuzick, Jack ;

Dillner, Joakim ;

Heideman, Danielle A. M. ;

Snijders, Peter J. F. .

INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) :516-520

[13] Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age [J].

Quigley, Neil B. ;

Potter, Nicholas T. ;

Chivukula, Mamatha ;

Knight, Mirna Z. ;

Welche, James R. ;

Olson, Marilyn C. .

JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (01) :23-27

[14]

Rossi PG, 2013, CURR PHARM DESIGN, V19, P1490

[15] Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the US Preventive Services Task Force [J].

Whitlock, Evelyn P. ;

Vesco, Kimberly K. ;

Eder, Michelle ;

Lin, Jennifer S. ;

Senger, Caitlyn A. ;

Burda, Brittany U. .

ANNALS OF INTERNAL MEDICINE, 2011, 155 (10) :687-+

[16] Clinical Experience with the Cervista HPV HR Assay Correlation of Cytology and HPV Status from 56,501 Specimens [J].

Youens, Kenneth E. ;

Hosler, Gregory A. ;

Washington, Paula J. ;

Jenevein, E. Patrick ;

Murphy, Kathleen M. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (02) :160-166

[17] Clinical Performance Characteristics of the Cervista HPV HR Test Kit in Cervical Cancer Screening in China [J].

Zhao, Jian ;

Zhang, Xiaoguang ;

Ma, Jing ;

Liu, Guiwen ;

Yao, Dianxin ;

Zhang, Weiyuan ;

Wang, Jiandong ;

Wei, Lihui ;

Zhao, Yun ;

Zeng, Yi ;

Liao, Qinping .

JOURNAL OF LOWER GENITAL TRACT DISEASE, 2012, 16 (04) :358-363

← 1 2 →